Axial Spondyloarthritis and Psoriatic Arthritis: Ixekizumab Study

We are examining how ixekizumab affects inflammation in patients with axial spondyloarthritis and psoriatic arthritis. This study uses whole-body MRI to measure changes in joints and entheses.

>2 years Monitoring phase (IV)No Placebo Standard Medicines InjectionOrthopedics and TraumatologyRheumatology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Taltz

Taltz is a prescription medicine used to treat moderate-to-severe plaque psoriasis and psoriatic arthritis.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Ixekizumab

Ixekizumab is a substance that targets an inflammatory protein to reduce skin inflammation in moderate-to-severe plaque psoriasis and related autoimmune conditions.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...

Gentofte Hospital

Klinik for Led- og Bindevævssygdomme

Charlottenlund, Denmark

Frederiksberg Hospital

Klinik for Led- og Bindevævssygdomme

Frederiksberg, Denmark

Rigshospitalet

Afdeling for Rygkirurgi, Led- og Bindevævssygdomme

Glostrup, Denmark

Sponsor: Rigshospitalet

Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.